8-Chlor-3-pentyl-3,7-dihydro-1H-purin-2,6-dion2-amino-2-(hydroxymethyl)-1,3-propandiolanhydrat til behandling af sygdomme

corresponding manufacture processes, pharmaceutical formulations containing and uses of the aforementioned compound in therapy, particularly in treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ESKEN, HOLLY, NORTON, BETH, ADAMS
Format: Patent
Sprache:dan
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:corresponding manufacture processes, pharmaceutical formulations containing and uses of the aforementioned compound in therapy, particularly in treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial.